covid
Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia Predictors of the persistence of childhood asthma
Información de la revista
Vol. 36. Núm. 2.
Páginas 66-71 (abril 2008)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
3221
Vol. 36. Núm. 2.
Páginas 66-71 (abril 2008)
ORIGINAL ARTICLES
Acceso a texto completo
Predictors of the persistence of childhood asthma
Visitas
3221
E.R. Cabanas Rodrigueza, F.J. Gonzalez Barcalab,
Autor para correspondencia
fjgbarcala@telefonica.net

Correspondence: F.J. Gonzalez Barcala. Servicio de Neumología Hospital Clínico Universitario de Santiago Travesía da Choupana, s/n. 15706 Santiago. A Coruña Phone: + 34-607819141 Fax number: + 34-981583312.
, P. Cabanas Rodriguezc, R. Leisc, B. Martinezd, R. Cabanasc, L. Valdes Cuadradob, R. Tojoc
a Departamento de Otorrinolaringología. Hospital Clínico Universitario. Santiago de Compostela. España
b Servicio de Neumología. Hospital Clínico Universitario. Santiago de Compostela. España
c Departamento de Pediatría. Universidad de Santiago de Compostela. España
d Servicio de Urgencias. Hospital Clínico Universitario de Santiago de Compostela. A Coruña. España
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (3)
Table I. Distribution of the sample, by sex and severity of asthma
Table II. Mean age at onset of symptoms and mean age at diagnosis, for each severity. Data are means ± standard deviations
Table III. Independent predictors at diagnosis of uncontrolled asthma at 5-year follow-up, with the corresponding odds ratios (OR) and 95 % confidence intervals (CI)
Mostrar másMostrar menos
ABSTRACT
Background

The factors relevant to the prognosis of childhood asthma differ from one population to another.

Objectives

To characterize the course of childhood asthma in the catchment area of our hospital, and to identify prognostic factors for this population.

Methods

All children given a diagnosis of asthma in the paediatric pulmonology service of a tertiary hospital were followed up for 5 years.

Results

Satisfactory control of asthma was achieved in 69 % of cases. The factors identified as associated with poor control were allergy to cats and pollen, a large number of crises in the year prior to diagnosis, and younger age at onset.

Conclusions

In our region, childhood asthma has a relatively favourable prognosis. The subsequent course of the disease appears to be determined in childhood. The persistence of symptoms appears to depend to a significant extent on the degree of atopy.

Key words:
Allergy
Longitudinal study
Paediatric asthma
Prognostic factor
Texto completo
INTRODUCTION

Recent decades have seen increases in the prevalence of childhood asthma, which, depending on the country considered, ranged from 2.1 % to 32.2%1. Although asthma involves both genetic and environmental factors, these increases appear most probably to have been due to the latter1.

Asthma being a chronic condition of variable course, it would seem desirable to identify factors associated with persistent disease so as to be able to identify asthmatic children with the greatest risk of persistence. Preferential attention to these patients would hopefully improve their long-term prognosis.

The factors that in previous studies have been found to increase the risk of persistence include other atopies, exposure to tobacco smoke, bronchial hyperresponsiveness, impaired lung function, and the severity of the disease1. In this work we studied the course of childhood asthma in the catchment area of our centre (the area around Santiago de Compostela, Spain; with a population of around 387,000 people covered by the public health system), and factors that might determine unfavourable prognosis.

MATERIALS AND METHODSPatíents and study desígn

The 669 children (60 % boys) who between June 1991 and February 1993 were given a diagnosis of asthma in the Allergy and Pulmonology Unit of the Paediatrics Department of the University Hospital, Santiago de Compostela (Spain), were each followed up for 5years. A posteriori, we included in this study the 249 (161 boys and 88 girls) whose records lacked no more than two of the data required for the study (see below, Study variables) and who, throughout follow-up, had been free of the following other conditions: a chronic pulmonary disease other than asthma, neuromuscular disease, mental retardation, gastro-oesophageal reflux, and chronic sinusitis.

Diagnosis and management

Diagnosis was carried out by the two paediatric respiratory physicians of the Unit (the same two throughout the study) in accordance with the guidelines of the U.S. National Asthma Education Program Expert Panel Report of 1991 (USNAEPEPR)2. Briefly, asthma was diagnosed if a) bronchodilatory treatment resolved recurrent episodes of coughing, dyspnea, wheezing or intolerance of exercise for which other aetiologies had been ruled out, and b) for children aged 6years or more, with compatible clinical symptoms and with spirometric results including a positive bronchodilation test consistent with a diagnosis of asthma. The severity of the disease was evaluated following U.S. National Institutes of Health (NIH) guidelines3.

All patients were provided with printed instructions on how to react to changes in symptoms, and with a list of nine recommendations for control of their environment. All were re-examined at least once a year in the same Unit.

During the course of the study the patients were managed by the physicians responsible for their diagnoses in accordance with USNAEPEPR 1991 guidelines2: mild asthma was treated with beta-2 agonists ad lib, and more severe forms already based on inhaled corticosteroids. Peak expiratory flow (PEF) was evaluated at each visit, and forced spirometry was performed at least once a year. Treatment was prescribed at each visit on the basis of severity and in view of the degree of adherence to treatment and environmental control recommendations. These patients can receive medicines for free.

Study variables and evaluation methods

The following parameters were studied, where pertinent, at each examination: sex; month of birth; age at diagnosis; age at onset of asthma; age of first consultation prompted by symptoms of asthma; family history of allergy (considering parents, siblings, parents' siblings and grandparents); the child's history of allergy; parents' smoking behaviour; presence of dogs or cats at home; number of crises or hospitalization episodes in the year prior to diagnosis, eosinophils in peripheral blood; serum IgE; skin test results for mites, grass pollen, dog, cat, Alternaría alternata and Aspergillus fumigatus (allergen extracts commercially available, from ALK-Abello); the severity of asthma, spirometric parameters (including bronchodilatory test results), treatment received, adherence to treatment, number of crises or hospitalization episodes during follow-up, and degree of control at 5-year follow-up.

Skin tests were performed as per Kurlat4. Adherence to therapy was evaluated on the basis of self-report plus observation of inhaler technique; adherence was deemed good if inhaler technique was correct and seven of the nine environmental control recommendations had been complied with. Asthma was deemed to be controlled if the patient had no symptoms, reported no limitation of everyday activity (including exercise), had normal PEF with a circadian variability of less than 20 %, and only very occasionally had to resort to beta-2 agonists3.

Statistical analysis

Statistical distributions were tested for deviation from normality using Kolmogorov-Smirnov tests. Normally distributed variables were compared using Student'st tests or analyses of variance, and non-normally distributed variables using Kruskal-Wallis or Mann-Whitney U tests. Variables shown by univariate analyses to be associated with differences in degree of control of asthma were subjected to multivariate logistic regression analysis for identification of the variables with independent effects and calculation of the corresponding odds ratios. All statistical analyses were performed using SPSS v.6.0.

RESULTS

At diagnosis, the 249 patients included in the study were aged 7.08 ± 3.09years (range 4-14years). Some 49 % lived in rural localities and 51 % in urban localities.

Only 12 patients (5 %) had persistent severe asthma at diagnosis, and for the purposes of statistical analysis they were pooled with the patients with persistent moderate asthma. This joint condition was more common among boys than among girls at diagnosis (Table I), and was diagnosed at a later age than less severe forms (Table II).

Table I.

Distribution of the sample, by sex and severity of asthma

  Boys n (%)  Girls n (%)  p* 
Intermittent  46 (29%)  27 (31%)  < 0.05 
Mild  34 (21%)  32 (36%)   
Moderate and severe  81 (50%)  29 (33%)   
Total  161 (100%)  88 (100%)   
*

For comparison of percentage of boys with percentage of girls.

Table II.

Mean age at onset of symptoms and mean age at diagnosis, for each severity. Data are means ± standard deviations

  Age at onset of symptoms (years)  p  Age at diagnosis (years)  p 
Intermittent  3.25 ± 2.57  Ns  6.18 ± 2.51  < 0.01 
Mild  3.50 ± 2.52    7.30 ± 3.22   
Moderate and severe  2.76 ± 2.68    7.55 ± 3.41   

Asthma was associated with allergy in 227 cases (91 %), and in all these cases there was allergy to mites. This coincided with allergy to pollen in 44 cases (18 %), and to cats in 69 (28 %).

As can be seen in Figure 1, at 5-year follow-up, adequate control of asthma had been achieved by 172 patients (69 %): 84 % of patients with an initial diagnosis of intermittent asthma; 68 % of those with initial mild persistent asthma; and 60 % of those with moderate or severe persistent asthma (p < 0.01). According to atopic response adequate control of asthma is more frequent between those not sensitized (by comparison with those sensitized). Adequate control has been achieved by 67 % of patients sensitized to mites and by 87 % not sensitized to mites (p < 0.05); by 52 % of those sensitized to pollen and 73 % of those not sensitized to pollen (p < 0.05); and 58 % of those sensitized to cats and 73 % of those not sensitized to cats (p < 0.05).

Figure 1.

Numbers of patients in each initial severity class who had achieved control of asthma at 5-year follow-up, with the corresponding percentages of the class total.

(0.05MB).

The variables shown by univariate analyses to be associated with poor control at 5-year follow-up were severity at diagnosis, poor adherence to treatment, specific allergen immunotherapy, allergy to cats or pollen, younger age at onset of the disease, and the number of crises or hospitalization episodes in the year prior to diagnosis (results not shown). Of these, those shown by multivariate logistic regression analysis to have independent effects were: allergy to cats; allergy to pollen; the number of crises or hospitalization episodes in the year prior to diagnosis; and younger age at onset (Table III). In particular, the risk of non-control was doubled by allergy to cats, and tripled by allergy to pollen.

Table III.

Independent predictors at diagnosis of uncontrolled asthma at 5-year follow-up, with the corresponding odds ratios (OR) and 95 % confidence intervals (CI)

Predictor  OR  CI 
Allergy to pollen  3.25  1.53-6.92 
Allergy to cats  2.15  1.14-4.08 
Crises or hospitalizations in the year prior to diagnosis  1.13  1.02-1.26 
Age at onset of symptoms  0.86  0.76-0.98 
DISCUSSION

In view of the geographical heterogeneity of the prevalence of childhood asthma5, it is desirable for factors associated with poor control to be identified for each geographical region. This study aimed to fulfil this need, for the catchment area of our hospital. We did not attempt to determine the prevalence or incidence of childhood asthma in this area, but our data do probably afford a reliable estimate of the distribution of asthma between the sexes; the ratio of 1.83:1, with greater prevalence among boys, is similar to that found in other studies6-9.

The proportion of patients achieving satisfactory control of asthma has varied widely from study to study. This has probably been largely due to differences among these studies as regards the evaluation of response to treatment, the definition of remission, the age of the patients, criteria for admission to the study, and the length of follow-up. Genetic, environmental and therapeutic differences may also have been involved. The generally satisfactory response of our patients may have been favoured by their having been managed by the specialists of a hospital Paediatric Allergy and Pulmonology Unit10-12.

Severity at diagnosis

Our findings agree with those of most other studies13-15; (the study by Mazón et al7 is an exception), in that severity at diagnosis was associated with the persistence of symptoms. Although NIH severity did not emerge as having an independent effect on control in the multivariate analysis, an independent effect was detected for the number of crises prior to diagnosis, which is also a measure of severity. This association is coherent with the reported association of severity with bronchial remodelling16 and with poor lung function in young adulthood17.

Poor prognosis has also been associated with the recurrence of infections, which are known to be associated with asthmatic crises. In particular, an adverse influence of respiratory syncytial virus has been reported18,19. Paradoxically, infections have been reported to protect against or ameliorate allergies20. It is also possible that upper airway infections are favoured by asthma, rather than the reverse21; certainly, the symptoms of viral infections are more intense and longer-lasting in asthmatic patients than in others22,23.

The poor prognosis of patients with greater severity at diagnosis suggests that good control of the disease at onset may reduce its effects in later life.

Age of onset

The prognostic implications of age of onset are also unclear. Like Kjellman and Hesselmar24, we found that earlier age at onset was associated with greater severity, but others have observed the reverse15,25 and others again no influence at all7,8,26, while Ulrik et al reported that earlier age at onset worsened prognosis for intrinsic asthma but not for extrinsic asthma27. When follow-up has been pursued to adulthood, age of onset has exhibited negative correlation with the risk of relapse in adulthood26. That earlier age of onset has unfavourable implications would be in keeping with the suggestion that onset may be initiated by viral infections that lead to alterations in the structure and function of the developing airways28, since the still-developing lungs of younger patients29 may be expected to be more susceptible of alteration than those of older patients. Such alterations would explain why, as noted above, the symptoms of viral infections are more intense and longer-lasting in asthmatic patients than in others22,23.

Atopy

In some studies, atopy has been found to have no influence on the persistence of asthma8,24,30,31, while in others it has been associated with poor prognosis7,9,25,32-35. Since the expression of atopy depends on both genetic factors and exposure to environmental stimuli19, discrepancies as to the allergens involved in atopy-associated persistence of asthma may be due to both kinds of factor, although differences in environmental exposure seem likely to predominate. For example, persistent wheezing was associated with an atopic response to house dust in New Zealand26, but with Alternaría in Arizona36.

Of the allergens considered in the present study, only pollen and cats increased the risk of persistence. An atopic response to cats was also found to be detrimental in a study carried out in Hungary6, although not so in certain other studies7,26. The atopy that in the present study most increased the risk of persistence, atopy to pollen, has not previously been reported to have an independent influence on persistence6,7,26, although its association with poor remission in a univariate analysis in Mazón et al's study7 suggests that its non-emergence in multivariate analyses may have been due to it being less allergenic than other allergens considered.

Since the persistence of subclinical airway inflammation most probably favours the persistence of asthmatic symptoms37,38, the relatively poor prognosis for atopic patients is in keeping with reports that they have greater airway inflammation than non-atopic patients, as evaluated by measurement of exhaled nitric oxide39. However, we do not know why atopy towards some allergens worsens prognosis while atopy towards others appears not to. This situation calls for prospective studies that include data on exposure and sensitization to a range of different allergens, and on the allergen-specific relationships of exposure and sensitization to the prognosis of asthma. Since the environmental allergen spectrum and the sensitization of the population both vary from one geographical location to another, studies of this kind are required for each relevant geographical unit40.

CONCLUSIONS

That satisfactory control was achieved for 69 % of the patients included in this study suggests that in our region the prognosis of childhood asthma is fairly favourable, as has been found in most published studies6,9,41. In the present case this conclusion is strengthened by it being reasonable to suppose that our patients were in general more severely affected than others in the community; all had been referred to hospital, and most of those who dropped out of the study probably did so because of remission or the persistence of only mild asthma. For the same reason, the high proportion of patients achieving satisfactory control appears to support the utility of specialized asthma units. It is possible, however, that because of these special characteristics of our study group, our findings as regards the predictors of unfavourable outcome may not be generalizable to the community in general. It remains to be seen whether stricter management of patients with the risk factors detected in this study will achieve a reduction in morbidity.

REFERENCES
[1.]
A. Host, S. Halken.
The role of allergy in childhood asthma.
Allergy, 55 (2000), pp. 600-608
[2.]
Guidelines for diagnosis and management of asthma.
National Asthma Education Program Expert Panel Report. U. S. Department of Health and Human Service. National Institute of Health, Public Health Service.
J Allergy Clin Immunol, 3 (1991), pp. 425-533
[3.]
National Institutes of Health: Global strategy for asthma management and prevention. NHLBI/WHO workshop report. NIH Publication No. 95-3659, 1995:1-176.
[4.]
D.M. Kurlat.
Métodos de diagnóstico.
Alergia en pediatría, pp. 32-43
[5.]
N. Pearce, N. Aït-Khaled, R. Beasley, J. Mallol, U. Keil, E. Mitchell, C. Robertson, The ISAAC Phase Three Study Group.
Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC).
Thorax, 62 (2007), pp. 758-766
[6.]
A. Halasz, E. Cserháti.
The prognosis of bronchial asthma in childhood in Hungary: A long-term follow-up.
J. Asthma, 39 (2002), pp. 693-699
[7.]
A. Mazon, A. Nieto, F.J. Nieto, R. Menendez, Boquete M., J. Brines.
Prognostic factors in childhood asthma: a logistic regression analysis.
Ann Allergy, 72 (1994), pp. 455-461
[8.]
O. Linna.
A 5-year prognosis of childhood asthma.
Acta Paediatr Scand, 74 (1985), pp. 442-445
[9.]
T. Nicolai, L. Pereszlenyiova-Bliznakova, S. Illi, D. Reinhardt, E. von Mutius.
Longitudinal follow-up of the changing gender ratio in asthma from childhood to adulthood: role of delayed manifestation in girls.
Pediatr Allergy Immunol, 14 (2003), pp. 280-283
[10.]
M. Schatz, R.S. Zeiger, D. Mosen, A.J. Apter, W.M. Vollmer, T.B. Stibolt, et al.
Improved asthma outcomes from allergy specialist care: a population-based cross-sectional analysis.
J Allergy Clin Immunol, 116 (2005), pp. 1307-1313
[11.]
C. Pellicer, R. Ramírez, M. Perpiñá, M.J. Cremades, J. Fullana, I. García, et al.
Ganancia, pérdida y concordancia en el diagnóstico de asma entre neumólogos y no neumólogos.
Arch Bronconeumol, 37 (2001), pp. 171-176
[12.]
W.M. Vollmer, M. O’Hollaren, K.M. Ettinger, T. Stibolt, J. Wilkins, A.S. Buist, et al.
Specialty differences in the management of asthma. A cross-sectional assessment of allergists’ patients and generalists’ patients in a large HMO.
Arch Inter Med, 157 (1998), pp. 1201-1208
[13.]
F. Rancé, H. Bataille, F. Brémont, J.L. Rittié, G. Dutau, A. Didier.
Prognostic à l’âge adulte de l’asthme de l’adolescent.
Rev Mal Respir, 17 (2000), pp. 1089-1093
[14.]
V. Plaza, J. Serra-Batlles, A. Cornella, C. Badiola.
Differences in asthma clinical outcomes according to initial severity.
J Asthma, 42 (2005), pp. 207-211
[15.]
M.A. Jenkins, J.L. Hopper, G. Bowes, J.B. Carlin, L.B. Flander, G.G. Giles.
Factors in childhood as predictors of asthma in adult life.
BMJ, 309 (1994), pp. 90-93
[16.]
A. Chetta, A. Foresi, M. Del Donno, G. Bertorelli, A. Pesci, D. Olivieri.
Airways remodeling is a distinctive feature of asthma and is related to severity of disease.
Chest, 111 (1997), pp. 852-857
[17.]
H. Oswald, P.D. Phelan, A. Lanigan, M. Hibbert, J.B. Carlin, G. Bowes, et al.
Childhood asthma and lung function in mid-adult life.
Pediatr Pulmonol, 23 (1997), pp. 14-20
[18.]
J. Henderson, T.N. Hilliard, A. Sherriff, D. Stalker, N. Al Shammari, H.M. Thomas.
Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study.
Pediatr Allergy Immunol, 16 (2005), pp. 386-392
[19.]
H.P. Van Bever, K.N. Desager, M. Hagendorens.
Critical evaluation of prognostic factors in childhood asthma.
Pediatr Allergy Immunol, 13 (2002), pp. 77-83
[20.]
E. von Mutius, S. Illi, T. Hirsch, W. Leupold, U. Keil, S.K. Weiland.
Frequency of infections and risk for asthma, atopy and airway hyperresponsiveness in children.
Eur Respir J, 14 (1999), pp. 4-11
[21.]
S. Illi, E. von Mutius, S. Lau, R. Bergmann, B. Niggemann, C. Sommerfeld, et al.
Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study.
BMJ, 322 (2001), pp. 390-395
[22.]
P. Xepapadaki, N.G. Papadopoulos, A. Bossios, E. Manoussakis, T. Manousakas, P. Saxoni-Papageorgiou.
Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy.
J Allergy Clin Immunol, 116 (2005), pp. 299-304
[23.]
P.W. Heymann, T.A. Platts-Mills, S.L. Johnston.
Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults.
Pediatr Infect Dis J, 24 (2005), pp. S217-S222
[24.]
B. Kjellman, B. Hesselmar.
Prognosis of asthma in children: a cohort study into adulthood.
Acta Paediatr, 83 (1994), pp. 854-861
[24.]
J.B. Clough, K.A. Keeping, L.C. Edwards, W.M. Freeman, J.A. Warner, J.O. Warner.
Can we predict which wheezy infants will continue to wheeze?.
Am J Respir Crit Care Med, 160 (1999), pp. 1473-1480
[26.]
M.R. Sears, J.M. Greene, A.R. Willan, E.M. Wiecek, D.R. Taylor, E.M. Flannery, et al.
A longitudinal, population-based, cohort study of childhood asthma followed to adulthood.
N Engl J Med, 349 (2003), pp. 1414-1422
[27.]
C.S. Ulrik, V. Backer, A. Dirksen, M. Pedersen, C. Koch.
Extrinsic and intrinsic asthma from childhood to adult age: a 10-year follow-up.
Respir Med, 89 (1995), pp. 547-554
[28.]
J.E. Gern, L.A. Rosenthal, R.L. Sorkness, R.F. Lemanske Jr.
Effects of viral respiratory infections on lung development and childhood asthma.
J Allergy Clin Immunol, 115 (2005), pp. 668-674
[29.]
American Thoracic Society ad hoc Statement Committee.
Mechanisms and limits of induced postnatal lung growth.
Am J Respir Crit Care Med, 170 (2004), pp. 319-343
[30.]
W. Xuan, G.B. Marks, B.G. Toelle, E. Belousova, J.K. Peat, G. Berry, et al.
Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness.
Thorax, 57 (2002), pp. 104-109
[31.]
R.J. Roorda, J. Gerritsen, W.MC. Van Aalderen, K. Knol.
Influence of a positive family history and associated allergic diseases on the natural course of asthma.
Clin Exp Allergy, 2 (1992), pp. 627-634
[32.]
E. Rönmark, E. Jonsson, T. Platts-Mills, B. Lundback.
Incidence and remission of asthma in schoolchildren: report from the obstructive lung disease in northern Sweden studies.
Pediatrics, 107 (2001), pp. E37
[33.]
A.A. Camara, J.M. Silva, V.P. Ferriani, K.R. Tobias, I.S. Macedo, M.A. Padovani, et al.
Risk factors for wheezing in a subtropical environment: role of respiratory viruses and allergen sensitisation.
J Allergy Clin Immunol, 113 (2004), pp. 551-557
[34.]
R.J. Kurukulaaratchy, S. Matthews, H. Arshad.
Does environment mediate earlier onset of the persistent childhood asthma phenotype?.
Pediatrics, 113 (2004), pp. 345-350
[35.]
M. Halonen, D.A. Stern, C. Lohman, A.L. Wright, M.A. Brown, F.D. Martinez.
Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk.
Am J Respir Crit Care Med, 160 (1999), pp. 564-657
[36.]
S. Guerra, A.L. Wright, W.J. Morgan, D.L. Sherrill, C.J. Holberg, F.D. Martinez.
Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty.
Am J Respir Crit Care Med, 170 (2004), pp. 78-85
[37.]
L.M. van den Toorn, S.E. Overbeek, J.C. de Jongste, K. Leman, H.C. Hoogsteden, J.B. Prins.
Airway inflammation is present during clinical remission of atopic asthma.
Am J Respir Crit Care Med, 164 (2001), pp. 2107-2113
[38.]
L.K. Arruda, D. Sole, C.E. Baena-Cagnani, C.K. Naspitz.
Risk factors for asthma and atopy.
Curr Opin Allergy Clin Immunol, 5 (2005), pp. 153-159
[39.]
A. Prasad, B. Langford, J.R. Stradling, L.P. Ho.
Exhaled nitric oxide as a screening tool for asthma in school children.
Respir Med, 100 (2006), pp. 167-173
[40.]
R.S. Gruchalla, J. Pongracic, M. Plaut, R. Evans 3rd, C.M. Visness, M. Walter, et al.
Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity.
J Allergy Clin Immunol, 115 (2005), pp. 478-485
[41.]
S.L. Limb, K.C. Brown, R.A. Wood, R.A. Wise, P.A. Eggleston, J. Tonascia, et al.
Adult asthma severity in individuals with a history of childhood asthma.
J Allergy Clin Immunol, 115 (2005), pp. 61-66
Copyright © 2008. Sociedad Española de Inmunología Clínica y Alergología Pediátrica y Elsevier España, S.L.
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aller.2020.01.003
No mostrar más